SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/BA25E286A33D47EC3B44F2D9FC0A0F6127D100779B31FDB345E5CDCD205E1DC066B6FE51F1DD2E76560D366B2E758F57>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/BA25E286A33D47EC3B44F2D9FC0A0F6127D100779B31FDB345E5CDCD205E1DC066B6FE51F1DD2E76560D366B2E758F57
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/BA25E286A33D47EC3B44F2D9FC0A0F6127D100779B31FDB345E5CDCD205E1DC066B6FE51F1DD2E76560D366B2E758F57
http://www.w3.org/2000/01/rdf-schema#comment
"ASAH1 inhibition synergistically sensitizes lung cancer cells resistant to the antiproliferative effect of choline kinase alpha inhibitors."
xsd:string
http://purl.uniprot.org/uniprot/#_CB4C0207531E209697662D190B449061F239E63008876A2AAC79C5F7D4E906676B3F8BCB0742DC55365C639943FD3A6F
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/BA25E286A33D47EC3B44F2D9FC0A0F6127D100779B31FDB345E5CDCD205E1DC066B6FE51F1DD2E76560D366B2E758F57
http://purl.uniprot.org/uniprot/P35790
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BA25E286A33D47EC3B44F2D9FC0A0F6127D100779B31FDB345E5CDCD205E1DC066B6FE51F1DD2E76560D366B2E758F57
http://purl.uniprot.org/uniprot/#_P35790-mappedCitation-22515519
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BA25E286A33D47EC3B44F2D9FC0A0F6127D100779B31FDB345E5CDCD205E1DC066B6FE51F1DD2E76560D366B2E758F57